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mRNA degradation by miRNAs
and GW182 requires both CCR4:NOT
deadenylase and DCP1:DCP2
decapping complexes
Isabelle Behm-Ansmant,1,4 Jan Rehwinkel,1,4 Tobias Doerks,1 Alexander Stark,3 Peer Bork,1
and Elisa Izaurralde1,2,5
1European Molecular Biology Laboratory (EMBL), D-69117 Heidelberg, Germany; 2Max-Planck-Institute for Developmental
Biology, D-72076 Tübingen, Germany
MicroRNAs (miRNAs) silence the expression of target genes post-transcriptionally. Their function is mediated
by the Argonaute proteins (AGOs), which colocalize to P-bodies with mRNA degradation enzymes.
Mammalian P-bodies are also marked by the GW182 protein, which interacts with the AGOs and is required
for miRNA function. We show that depletion of GW182 leads to changes in mRNA expression profiles
strikingly similar to those observed in cells depleted of the essential Drosophila miRNA effector AGO1,
indicating that GW182 functions in the miRNA pathway. When GW182 is bound to a reporter transcript, it
silences its expression, bypassing the requirement for AGO1. Silencing by GW182 is effected by changes in
protein expression and mRNA stability. Similarly, miRNAs silence gene expression by repressing protein
expression and/or by promoting mRNA decay, and both mechanisms require GW182. mRNA degradation, but
not translational repression, by GW182 or miRNAs is inhibited in cells depleted of CAF1, NOT1, or the
decapping DCP1:DCP2 complex. We further show that the N-terminal GW repeats of GW182 interact with
the PIWI domain of AGO1. Our findings indicate that GW182 links the miRNA pathway to mRNA
degradation by interacting with AGO1 and promoting decay of at least a subset of miRNA targets.
[Keywords: Argonaute; deadenylation; decapping; GW182; mRNA decay; P-bodies]
Supplemental material is available at http://www.genesdev.org.
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RNA silencing pathways are conserved, and regulate
gene expression at both transcriptional and post-tran-
scriptional levels. These pathways are triggered by the
presence of double-stranded RNAs (dsRNAs) of diverse
origin, which are processed into small RNAs of 20–30
nucleotides in length. MicroRNAs (miRNAs) are a spe-
cific class of genome-encoded small RNAs that regulate
gene expression post-transcriptionally (Bartel 2004; Fili-
powicz 2005). We now know of hundreds of miRNAs in
different organisms, and each is thought to regulate the
expression of hundreds of targets. They are implicated in
biological processes as diverse as cell differentiation and
proliferation, apoptosis, metabolism, and development
(Bartel 2004; Filipowicz 2005).
To accomplish their regulatory function miRNAs as-
sociate with the Argonaute proteins to form RNA-in-
duced silencing complexes (RISCs), which elicit decay or
translational repression of complementary mRNA tar-
gets (Bartel 2004; Filipowicz 2005). In plants, miRNAs
are often fully complementary to their targets, and elicit
mRNA decay. In contrast, animal miRNAs are only par-
tially complementary to their targets, and silence gene
expression by mechanisms that remain elusive (Filipow-
icz 2005). Recent studies have shown that miRNAs si-
lence gene expression by inhibiting translation initiation
at an early stage involving the cap structure, as mRNAs
translated via cap-independent mechanisms escape
miRNA-mediated silencing (Humphreys et al. 2005; Pil-
lai et al. 2005). Other studies have suggested that trans-
lation inhibition occurs after initiation, based on the ob-
servation that miRNAs and some targets remain associ-
ated with polysomes (Olsen and Ambros 1999; Kim et al.
2004; Nelson et al. 2004; Petersen et al. 2006). In addi-
tion, animal miRNAs can also induce significant degra-
dation of mRNA targets despite imperfect mRNA–
miRNA base-pairing (Bagga et al. 2005; Jing et al. 2005;
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Lim et al. 2005; Giraldez et al. 2006; Rehwinkel et al.
2006; Wu et al. 2006).
The existence of a link between the miRNA path-
way and mRNA decay is supported by the observation
that mammalian Argonaute proteins (AGO1–AGO4),
miRNAs, and miRNA targets colocalize to cytoplasmic
foci known as P-bodies (Jakymiw et al. 2005; Liu et al.
2005a,b; Meister et al. 2005; Pillai et al. 2005; Sen and
Blau 2005). These mRNA processing bodies are discrete
cytoplasmic domains where proteins required for bulk
mRNA degradation in the 5-to-3 direction accumulate
(e.g., the decapping DCP1:DCP2 complex and the 5-to-
3 exonuclease XRN1) (for review, see Valencia-Sanchez
et al. 2006). Additional components of P-bodies in yeast
and/or human cells include the CCR4:NOT deadenylase
complex, auxiliary decapping factors (e.g., the LSm1–7
complex and Pat1p/Mtr1p), the cap-binding protein
eIF4E, and the RNA helicase Dhh1/Me31B involved in
translational repression (Valencia-Sanchez et al. 2006).
In metazoa, P-bodies are also marked by the presence of
GW182, a protein with glycine–tryptophan repeats (GW
repeats) required for P-body integrity (Eystathioy et al.
2002, 2003).
The presence of Argonaute proteins, miRNAs, and
miRNA targets in P-bodies has led to a model in which
translationally silenced mRNAs are sequestered to these
bodies, where they may undergo decay (Jakymiw et al.
2005; Liu et al. 2005a,b; Meister et al. 2005; Pillai et al.
2005; Rehwinkel et al. 2005; Sen and Blau 2005). At pres-
ent, it is unclear whether the localization in P-bodies is
the cause or consequence of the translational repression,
though several lines of evidence point to a direct role for
P-body components in miRNA-mediated gene silencing.
First, DCP1, GW182, and its paralog TNRC6B associate
with AGO1 and AGO2 in human cells (Jakymiw et al.
2005; Liu et al. 2005a,b; Meister et al. 2005; Sen and Blau
2005). Second, depletion of GW182 in human cells im-
pairs both miRNA function and mRNA decay triggered
by complementary short interfering RNAs (siRNAs) (Ja-
kymiw et al. 2005; Liu et al. 2005b; Meister et al. 2005).
Similarly, miRNA function is impaired in Drosophila
Schneider cells (S2 cells) depleted of GW182 or the de-
capping DCP1:DCP2 complex (Rehwinkel et al. 2005).
Finally, the Caenorhabditis elegans protein AIN-1,
which is related to GW182, is required for gene regula-
tion by at least a subset of miRNAs (Ding et al. 2005).
In Drosophila, siRNA-guided endonucleolytic cleav-
age of mRNAs (RNA interference [RNAi]) is mediated by
AGO2, while gene silencing by miRNAs is mediated by
AGO1 (Okamura et al. 2004; Rand et al. 2004; Miyoshi
et al. 2005; Rehwinkel et al. 2005). That siRNAs and
miRNAs enter separate pathways in Drosophila is fur-
ther supported by the observation that depletion of
GW182 inhibits miRNA-mediated, but not siRNA-me-
diated gene silencing (Rehwinkel et al. 2005). The pre-
cise role of GW182 in the miRNA pathway is unknown.
GW182 could have an indirect role by affecting P-body
integrity. Alternatively, it could be more directly in-
volved, localizing miRNA targets to P-bodies or facili-
tating the mRNP remodeling steps required for the si-
lencing and/or decay of these targets (Jakymiw et al.
2005; Liu et al. 2005b; Meister et al. 2005; Rehwinkel et
al. 2005).
In this study, we further investigate the role of Dro-
sophila GW182 in the miRNA pathway. We show that
depletion of GW182 leads to changes in mRNA expres-
sion profiles strikingly similar to those observed in cells
depleted of AGO1, indicating that GW182 is a genuine
component of the miRNA pathway. In cells in which
miRNA-mediated gene silencing is suppressed by deple-
tion of AGO1, GW182 can still silence the expression of
bound mRNAs, suggesting that GW182 acts down-
stream of AGO1. We further show that GW182 triggers
silencing of bound transcripts by inhibiting protein ex-
pression and promoting mRNA decay via a deadenyla-
tion and decapping mechanism. Finally, we provide evi-
dence that mRNA degradation by miRNAs requires
GW182, the CCR4:NOT deadenylase, and the
DCP1:DCP2 decapping complexes. Together with the
observation that GW182 interacts with AGO1, our re-
sults indicate that binding of GW182 to miRNA targets
induces silencing and can trigger mRNA degradation,
providing an explanation for the observed changes in
mRNA levels, at least for a subset of animal miRNA
targets.
Results
Drosophila GW182 functions in the miRNA pathway
To investigate whether GW182 functions in the miRNA
pathway or has additional roles in mRNA turnover, we
compared RNA expression profiles of GW182-depleted
cells with those of AGO1- or AGO2-depleted cells, using
high-density oligonucleotide microarrays. For each pro-
tein, we obtained expression profiles from two or three
independent RNA samples. As a reference, RNA samples
were isolated from mock-treated cells. We also examined
mRNA profiles in cells treated with GFP (green fluores-
cent protein) dsRNA to identify mRNAs that are likely
to be regulated nonspecifically in response to the dsRNA
treatment.
Western blot analysis indicated that the residual levels
of the proteins in depleted cells were <10% of those ob-
served in control cells (Fig. 1A, lanes 5,12 vs. 1,7). Im-
portantly, depletion of AGO1 does not affect the expres-
sion of GW182 or AGO2 (Fig. 1A, lane 11; data not
shown). Conversely, GW182 depletion had no effect on
AGO1 or AGO2 expression levels (Fig. 1A, lane 6; data
not shown).
The profiles displayed by cells depleted of GW182 or
AGO1 were strikingly similar (Fig. 1B). The rank corre-
lation coefficient r between GW182 and AGO1 profiles
was 0.92, indicating that these proteins regulate com-
mon targets. A subset of these targets was also regulated
by AGO2 (Fig. 1B). The rank correlation coefficient was
0.64 between GW182 and AGO2 profiles, and 0.63 be-
tween AGO1 and AGO2. Indeed, we have shown before
that AGO2 affects the expression of a subset of tran-
scripts regulated by AGO1, and that only a few tran-
scripts are exclusively regulated by AGO2 in S2 cells
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1886 GENES & DEVELOPMENT
 Cold Spring Harbor Laboratory Press on April 2, 2014 - Published by genesdev.cshlp.orgDownloaded from 
(Rehwinkel et al. 2006). For this reason AGO2 profiles
were not considered further.
To investigate the similarity of the cellular response to
the depletion of GW182 and AGO1, we selected mRNAs
belonging to specific classes in the GW182 knockdown
(at least twofold overrepresented or twofold underrepre-
sented, respectively) and analyzed their levels in the
AGO1 knockdown (Fig. 1C). There was a high degree of
overlap between regulated transcripts in the two knock-
downs (Fig. 1C; Supplementary Table 1). Indeed, among
the 423 mRNAs that were at least twofold overrepre-
sented in the GW182 knockdown, 75.8% changed levels
concordantly in AGO1-depleted cells and were at least
twofold up-regulated (Fig. 1C). Conversely, among the
486 mRNAs that were at least twofold overrepresented
in the AGO1 knockdown, 66% were twofold up-regu-
lated in the GW182 knockdown (Fig. 1D; Supplementary
Table 1). Down-regulated transcripts overlapped to a
similar extent (Fig. 1C,D; Supplementary Table 1).
Transcripts up-regulated in AGO1-depleted cells are
significantly enriched in predicted miRNA targets (Reh-
winkel et al. 2006). We tested the enrichment for targets
of cloned, nonredundant miRNAs (i.e., unique seed se-
quences) predicted by Stark et al. (2005). We observed a
significant enrichment for predicted miRNA targets
among transcripts up-regulated in the GW182 knock-
down (P = 6 × 10−20) and AGO1 knockdown (P = 3.2 × 10−32).
Consistently, the levels of detectable, experimentally
validated miRNA targets were at least twofold up-regu-
lated in cells depleted of GW182 or AGO1 (Fig. 1E). We
validated the array data for a subset of predicted miRNA
targets by Northern blot (Fig. 1F; data not shown). Down-
regulated transcripts were not significantly enriched for
predicted targets (P ∼ 1), suggesting that these transcripts
are unlikely to be directly regulated by the miRNA path-
way.
To determine whether GW182 has additional func-
Figure 1. Expression profiles of Drosophila S2 cells depleted of
GW182, AGO1, or AGO2. (A) S2 cells were treated with the
dsRNAs indicated above the lanes. The effectiveness of the
depletions was analyzed by Western blot with the antibodies
indicated on the left. In lanes 1–4, dilutions of samples isolated
from control cells were loaded to assess the efficacy of the deple-
tion. Antibodies against tubulin were used as a loading control.
(KD) Knockdowns. (B) Comparison of the average expression
levels of the 6345 detectable transcripts in the profiles obtained
for AGO1, GW182, or AGO2. The rank correlation coefficient
of the profiles (r) is indicated. The table shows the percentage of
transcripts at least twofold overrepresented (red), between two-
fold up- and down-regulated (yellow), or at least twofold under-
represented (blue). (C) Expression profiles of RNAs at least two-
fold overrepresented or underrepresented in the two indepen-
dent profiles obtained for GW182 (Supplementary Table 1). (D)
Expression profiles of RNAs at least twofold overrepresented or
underrepresented in the two profiles obtained for AGO1
(Supplementary Table 1). (E) Expression profiles of validated
miRNA targets. Asterisks indicate endogenous targets used to
generate the miRNA reporters shown in Figure 5. (F) Validation
of microarray results by Northern blot analysis. The identity of
the selected transcripts and the predicted cognate miRNAs are
indicated on the right. The signals from the Northern blot were
normalized to rp49 mRNA (not shown). These values are com-
pared with the values measured by microarray. Values are given
as fold changes relative to the values obtained in mock-treated
(cont.) cells. (G) Transcripts at least twofold regulated in either
AGO1 or GW182 samples and <1.3-fold changed or inversely
correlated in GW182 or AGO1 samples, respectively, and tran-
scripts regulated exclusively by AGO2.
GW182 links the miRNA pathway to mRNA decay
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tions in mRNA turnover, we sought transcripts regu-
lated exclusively in GW182-depleted cells but clearly
unaffected (changed <1.3-fold) or even showing inverse
correlation in the AGO1 knockdown. Only six tran-
scripts were found to be regulated exclusively in GW182-
depleted cells (Fig. 1G).
We also analyzed whether transcripts exclusively
regulated by AGO2 but not by the miRNA pathway (as
described by Rehwinkel et al. 2006) were affected by
GW182 depletion. We found that these transcripts were
not regulated by GW182 (Fig. 1G), a result consistent
with the possibility that AGO2 regulates the expression
of these transcripts by a mechanism involving endog-
enous siRNAs, whose function is not affected in GW182-
depleted cells (Rehwinkel et al. 2005). To summarize,
GW182 and AGO1 regulate a common set of mRNAs
that are significantly enriched in predicted and validated
miRNA targets, indicating that these proteins act in the
miRNA pathway; a subset of these targets is also regu-
lated by AGO2, as reported before (Rehwinkel et al.
2006).
GW182 belongs to a conserved family of proteins
present only in metazoa
To identify potential functional domains in GW182 we
compared orthologous sequences across species. PSI-
BLAST searches (Altschul et al. 1997) using Drosophila
and human GW182 as input sequences (Eystathioy et al.
2002; Rehwinkel et al. 2005) led to the identification of
single genes encoding GW182 orthologs in Drosophila
melanogaster, Anopheles gambiae, and Apis mellifera
genomic sequences, and three paralogous genes in Danio
rerio, Gallus gallus, Mus musculus, Rattus norvegicus,
and Homo sapiens, suggesting that duplication of the
GW182 gene occurred after the divergence of inverte-
brates and vertebrates. The three paralogs in vertebrates
are known as trinucleotide repeat containing (TNRC)
proteins 6A, 6B, and 6C. TNRC6A corresponds to
GW182 (Eystathioy et al. 2002; Meister et al. 2005).
The GW182 protein family is characterized by the
presence of a central ubiquitin-associated (UBA) domain
and a C-terminal RNA recognition motif (RRM) (Fig.
2A). Furthermore, three distinctive blocks of glycine–
tryptophan repeats (referred to as N-terminal, middle,
and C-terminal GW repeats) can be found, as well as a
glutamine-rich (Q-rich) region located between the UBA
domain and the RRM (Fig. 2A). The RRM and the N-
terminal GW repeats have been described before (Eysta-
thioy et al. 2002). The UBA domain was not found above
the significance threshold in all family members, but
iterative PSI-BLAST searches unambiguously confirmed
the UBA homology for all family members.
In addition, a multiple sequence alignment of the pro-
tein family sequences revealed two highly conserved
motifs (I and II) of ∼50 residues within the N-terminal
GW repeats (Fig. 2A). The insect proteins are shorter
than the vertebrate orthologs, and start exactly with mo-
tif I (Fig. 2A).
Motif II, the UBA, and the Q-rich domains are
required for the localization of GW182
in cytoplasmic foci
We examined the subcellular localization of Drosophila
GW182 in S2 cells using an antibody raised against the
RRM domain. The GW182 signal was detected through-
out the cytoplasm and in discrete cytoplasmic foci of
varying number and size (Fig. 2B). Similarly, transiently
expressed hemagglutinin (HA)- or GFP-tagged GW182 lo-
calized in cytoplasmic foci, indicating that the localiza-
tion of these proteins reflects that of endogenous GW182
(Fig. 2C; data not shown). To investigate whether these
Figure 2. The N-terminal domain of GW182 is required for
P-body targeting. (A) Domain architecture of GW182 and re-
lated proteins. (N-GW) N-terminal GW repeats; (M-GW) middle
GW repeats; (C-GW) C-terminal GW repeats; (UBA) ubiquitin-
associated domain; (Q-rich) region rich in glutamine; (RRM)
RNA recognition motif. Orange and red boxes I and II indicate
two conserved motifs within the N-terminal GW repeats. Num-
bers under the protein outline represent amino acid positions at
fragment boundaries for the Drosophila protein. The protein
domains sufficient for the localization to P-bodies and the in-
teraction with AGO1 are indicated. (B) Confocal fluorescent
micrograph of S2 cells stained with anti-GW182 antibodies. (C–
F) Confocal fluorescent micrographs of S2 cells expressing HA-
GW182 and/or GFP-DCP1. Bar, 5 µm.
Behm-Ansmant et al.
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GW182 foci are related to P-bodies, we transfected S2
cells with HA-GW182 and GFP fusions of known P-body
components (e.g., DCP1, DCP2, and Me31B). HA-
GW182 colocalized with the GFP-tagged proteins in cy-
toplasmic foci (Fig. 2E,F; data not shown), suggesting
that these foci represent P-body-like structures. Analysis
of the subcellular localization of HA-GW182 protein
fragments indicate that the N-terminal GW repeats in-
cluding motif II, the UBA, and the Q-rich domains all
contribute to the localization of GW182 in cytoplasmic
foci, though none of these domains suffice on their own
(Fig. 2A; Supplementary Fig. S1).
The N-terminal GW repeats of GW182 interact
with the PIWI domain of AGO1
In human cells, GW182 copurifies with Argonaute pro-
teins and promotes their recruitment to P-bodies (Jaky-
miw et al. 2005; Liu et al. 2005a,b; Meister et al. 2005;
Sen and Blau 2005). The protein domains mediating the
interaction between GW182 and AGOs have not been
defined in previous studies. We observed that Drosophila
AGO1 coimmunoprecipitated with HA-GW182 from S2
cell lysates, but not with the negative control, an HA
fusion of maltose-binding protein (MBP) (Fig. 3A, lanes
9,10). Moreover, GFP-AGO1 spreads throughout the cy-
toplasm in transiently transfected S2 cells, but accumu-
lates in cytoplasmic foci in cells coexpressing HA-
GW182 (Fig. 3, B vs. C,D). GFP-AGO1 was recruited ef-
ficiently to the foci formed by the N-terminal domain of
GW182 (amino acids 1–861) (Fig. 3E), and endogenous
AGO1 coimmunoprecipitated with this fragment (Fig.
3A, lane 11). C-terminal GW182 fragments (e.g., amino
acids 861–1384) do not localize in cytoplasmic foci
(Supplementary Fig. S1), and neither interact with AGO1
nor induce its accumulation in foci when coexpressed
Figure 3. The N-terminal domain of GW182 interacts with the PIWI domain of AGO1. (A) HA-GW182 or the indicated protein
fragments were transiently expressed in S2 cells. Cell lysates were immunoprecipitated using anti-HA antibodies. HA-MBP served as
a negative control. Inputs and immunoprecipitates were analyzed by Western blot using anti-HA or anti-AGO1 antibodies. (B–G)
Epitope-tagged GFP-AGO1 was expressed in S2 cells. In C–G, the effect of cotransfecting HA-tagged versions of GW182 or the
indicated protein fragments on the localization of AGO1 was examined. The merged images show the GFP signal in green, the HA
signal in red, and DNA in blue. Bar, 5 µm. (H) GST pull-down assays were performed with [35S]methionine-labeled full-length AGO1,
AGO2, or the indicated AGO1 protein fragments, and recombinant GST or GST-GW182 (fragment 1–592). Samples were analyzed by
SDS-PAGE followed by fluorography.
GW182 links the miRNA pathway to mRNA decay
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(Fig. 3A [lanes 12,16], F). We conclude that it is the N-
terminal domain of GW182 that associates with AGO1
in vivo.
Further analysis indicates that fragments 1–592 and
1–539 are sufficient to coimmunoprecipitate AGO1,
while the Q-rich domain, which is required for the lo-
calization to P-body-like structures, is inessential (Fig.
3A, lanes 13–15). Thus, binding to AGO1 and localiza-
tion to cytoplasmic foci are mediated by partially over-
lapping but distinct domains (Fig. 2A). The recruitment
of GFP-AGO1 to GW182 foci is not due to an unspecific
aggregation of overexpressed interacting partners be-
cause GW182 fragments 1–592 and 1–539, which inter-
act with AGO1 but do not form foci, do not induce the
aggregation of GFP-AGO1 in the cytoplasm (Fig. 3G;
data not shown). Moreover, GFP-AGO1 is not recruited
to cytoplasmic foci formed by various P-body compo-
nents including DCP2 or Ge-1 (Supplementary Fig. S1;
data not shown).
To define the domain of AGO1 interacting with
GW182, we performed pull-down experiments using
recombinant GW182 fragment 1–592 fused to glutathi-
one S-transferase and in vitro translated AGO1 (either
full-length or lacking the PIWI domain [amino acids
1–714]). We also tested AGO1 fragments lacking both
the PIWI and middle domains (amino acids 1–464), or
comprising the PIWI domain alone (amino acids 714–
984). We observed that the PIWI domain of AGO1 was
necessary and sufficient for its interaction with GW182
(Fig. 3H).
Remarkably, GW182 did not interact detectably with
AGO2 in pull-down or coimmunoprecipitation assays
(Fig. 3H; data not shown). The specific interaction of
GW182 with AGO1, but not AGO2, is consistent with a
role for GW182 in the miRNA, but not the siRNA path-
way (Rehwinkel et al. 2005).
GW182 silences the expression of bound mRNAs
To shed light on the role of GW182 in the miRNA path-
way, we investigated whether binding of this protein to
an mRNA is sufficient to silence its expression. To this
end, we made use of the tethering assay described by
Pillai et al. (2004). This assay involves the expression of
N-fusion proteins that bind with high affinity to five
BoxB sites (5BoxB) in the 3 untranslated region (UTR) of
a luciferase reporter mRNA (F-Luc-5BoxB reporter) (Fig.
4A).
S2 cells were transiently transfected with the F-Luc-
5BoxB reporter, a plasmid expressing GW182 fused to the
N-peptide (N-GW182), and a plasmid encoding Renilla
Figure 4. GW182 silences the expression of bound transcripts.
(A) Schematic representation of the F-Luc-5BoxB tethering re-
porter and of the F-Luc reporter control. (B,C) S2 cells were
transfected with the F-Luc-5BoxB reporter or the F-Luc control,
a plasmid expressing Renilla luciferase, and vectors expressing
the N-peptide or N-GW182. Firefly luciferase activity was
normalized to that of Renilla and set to 100 in cells expressing
the N-peptide alone. Mean values ± standard deviations from
four independent experiments (n = 4) are shown. In C, the cor-
responding RNA samples were analyzed by Northern blot. (D)
F-Luc-5BoxB or F-Luc mRNA levels were quantitated and nor-
malized to the R-Luc transfection control in four independent
experiments, including that shown in C. Normalized F-Luc
mRNA levels in cells expressing the N peptide alone were set
to 100%. Mean values are shown. Error bars represent standard
deviations. (E) The normalized values of firefly luciferase activ-
ity shown in B were divided by the normalized mRNA levels
shown in D to estimate the net effect of tethering GW182 on
protein synthesis. (F,G) S2 cells were transfected with plasmids
for the N-tethering assay. Cells were harvested at the indicated
time points after addition of actinomycin D. The decay of the
F-Luc-5BoxB mRNA was monitored in cells expressing the N-
peptide (F) or N-GW182 (G). (H) The levels of the F-Luc-5BoxB
mRNA normalized to rp49 mRNA in three independent experi-
ments are plotted against time. mRNA half-lives (t1/2) calcu-
lated from the decay curves are indicated.
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luciferase (R-Luc) as a transfection control. In the experi-
ments described below, the firefly luciferase activity was
normalized to that of Renilla to compensate for possible
differences in transfection efficiencies.
We observed a 16-fold reduction in firefly luciferase
expression relative to that in cells expressing the N-
peptide alone when N-GW182 was tethered to the re-
porter transcript (Fig. 4B). The inhibitory effect of N-
GW182 on the expression of the F-Luc-5BoxB reporter
was observed even when the amount of plasmid express-
ing N-GW182 was reduced 200-fold (data not shown),
suggesting that GW182 is a potent silencer of gene ex-
pression. Importantly, under these conditions other P-
body components fused to the N-peptide showed no
activity even if their expression levels were comparable
to or higher than those of GW182 (e.g., N-Ge-1, N-
Staufen, N-DCP1, N-Me31B), indicating that the si-
lencing activity of GW182 is specific and not a generic
property of P-body components. Moreover, the inhibi-
tory effect of N-GW182 affects only tethered mRNA,
while a firefly luciferase reporter lacking the 5BoxB-
binding sites is unaffected by overexpressed protein (F-
Luc) (Fig. 4A,B).
To determine whether GW182 silences firefly lucifer-
ase expression by inhibiting translation directly or indi-
rectly by reducing mRNA levels, we analyzed the steady-
state levels of the F-Luc-5BoxB mRNA by Northern blot
and normalized them to the levels of the control R-Luc
mRNA. Expression of the N-GW182 fusion caused a
marked reduction in the levels of the reporter mRNA
(fourfold relative to the levels detected in cells express-
ing the N-peptide alone) (Fig. 4C,D). We saw no effect
on transcripts lacking the tethering sites (Fig. 4C,D).
The decrease in mRNA levels observed for the teth-
ered mRNA does not, however, fully account for the
strong reduction in firefly luciferase activity (Fig. 4, B vs.
D). Indeed, after normalizing firefly luciferase activity to
the corresponding mRNA levels, we saw that bound N-
GW182 leads to a net fourfold reduction in protein ex-
pression (Fig. 4E). These results suggest that GW182 si-
lences expression of bound transcripts by two mecha-
nisms: one involving inhibition of protein expression,
and one involving a reduction of mRNA levels.
GW182 increases the degradation rate
of bound mRNAs
We next asked whether the reduction of reporter mRNA
levels caused by tethering of N-GW182 was a conse-
quence of increased mRNA degradation. To this end, the
levels of F-Luc-5BoxB mRNA were analyzed over time af-
ter inhibition of transcription by actinomycin D and nor-
malized to those of the long-lived (half-life > 8 h) endog-
enous rp49 mRNA (which encodes ribosomal protein L32).
In cells expressing the N-peptide alone, the half-life
of F-Luc-5BoxB mRNA was ∼3 h, while in cells express-
ing N-GW182, the half-life of this mRNA was ∼10 min
(Fig. 4F–H). mRNAs bound to N-GW182 had biphasic
decay kinetics, suggesting the existence of a hetero-
geneous pool of mRNAs (e.g., bound to GW182 with dif-
ferent stoichiometries) undergoing different rates of deg-
radation.
The half-lives of mRNAs lacking the tethering sites
(F-Luc and the transfection control R-Luc mRNA) were
not affected in cells expressing N-GW182 (Supplemen-
tary Fig. S2; data not shown). Thus, tethering of GW182
causes a reduction of the steady-state levels of bound
mRNAs by increasing their degradation rate. We con-
clude that the recruitment of GW182 (as mimicked in
the tethering assay) marks bound mRNAs for decay.
GW182 promotes mRNA deadenylation by recruiting
the CCR4:NOT complex
In cells expressing GW182, the F-Luc-5BoxB transcripts
accumulating 15–30 min after addition of actinomycin D
were slightly shorter than transcripts isolated at time 0
(Fig. 4G). This increase in mobility suggests that
GW182-mediated decay involves deadenylation. We
therefore tested whether transcripts accumulating in
cells expressing GW182 were polyadenylated. If this
were the case, we would expect these transcripts to
change their electrophoretic mobility upon removal of
the poly(A)-tail by oligo(dT)-targeted ribonuclease H
(RNase H) cleavage. When RNA samples isolated at time
0 were analyzed, both the F-Luc-5BoxB and the rp49
mRNAs changed mobility following removal of the
poly(A)-tail, indicating that these mRNAs were polyade-
nylated (Fig. 5A, lanes 1,2). In contrast, for RNA samples
isolated 15 min after the transcription block, the mobil-
ity of the luciferase reporter did not change after RNase
H treatment in the presence of oligo(dT), while that of
the rp49 mRNA did (Fig. 5A, lanes 3,4). These results
indicate that GW182-mediated decay does involve dead-
enylation.
There are two major deadenylase complexes in Dro-
sophila: the PAN2:PAN3 and the CCR4:NOT com-
plexes (Temme et al. 2004). To investigate which of
these complexes is involved in deadenylating mRNAs
bound to GW182, we performed the tethering assay in
cells depleted of PAN2, PAN3, or of two components of
the CCR4:NOT complex (CAF1 and NOT1), whose
depletion has been shown to affect deadenylation in S2
cells (Temme et al. 2004). In cells depleted of NOT1 (but
not of PAN2:PAN3), the levels of the F-Luc-5BoxB
mRNA bound to N-GW182 were partially restored (Fig.
5B,C), suggesting that GW182 requires the CCR4:NOT
complex to degrade bound mRNAs efficiently. Depletion
of CAF1, which leads to a simultaneous codepletion of
CCR4 (Temme et al. 2004), also restored F-Luc-5BoxB
mRNA levels, but to a lesser extent than the depletion of
NOT1 (Fig. 5B,C). No restoration was observed in cells
depleted of additional components of the CCR4:NOT
complex (data not shown), suggesting that in S2 cells
inactivation of this complex is most efficiently achieved
by depletion of CAF1 or NOT1, as reported by Temme et
al. (2004). Interestingly, the restoration of mRNA levels
resulted in only a slight increase of firefly luciferase ac-
tivity, indicating that the F-Luc-5BoxB mRNA was still
translationally repressed (Fig. 5B).
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mRNA decay by GW182 requires the DCP1:DCP2
decapping complex
Given the role of the decapping DCP1:DCP2 complex in
the miRNA pathway (Rehwinkel et al. 2005), we tested
whether mRNA degradation triggered by GW182 also
required decapping. To this end, we performed the N-
tethering assay in cells depleted of the DCP1:DCP2 de-
capping complex. Codepletion of DCP1 and DCP2 did
not relieve the inhibition of luciferase expression caused
by tethered GW182 (Fig. 5B).
When mRNA levels where analyzed, we observed that
depletion of the decapping complex restored the levels of
the reporter mRNA up to the levels observed in depleted
cells expressing the N-peptide alone (Fig. 5B,C). Never-
theless, in cells expressing N-GW182, the accumulated
transcripts were shorter and comigrate with the dead-
enylated form (Fig. 5C,D). This finding provides a pos-
sible explanation for the lack of restoration of luciferase
activity despite restoration of mRNA levels, since less
efficient translation of deadenylated transcripts is to be
expected. Altogether, our results indicate that GW182-
mediated mRNA decay involves deadenylation by the
CCR4:NOT complex and decapping by the DCP1:DCP2
complex.
mRNA decay triggered by miRNAs occurs via
a deadenylation and decapping mechanism
requiring GW182
To assess whether mRNA degradation by miRNAs is
dependent on GW182 and involves the CCR4:NOT and
DCP1:DCP2 complexes, we made use of firefly lucifer-
ase reporters described before (Rehwinkel et al. 2005). In
these reporters the coding region of firefly luciferase is
flanked by the 3 UTRs of the Drosophila gene CG10011
(F-Luc-CG10011), regulated by miR-12, and of Nerfin or
Vha68-1 (F-Luc-Nerfin, F-Luc-Vha68-1), regulated by
miR-9b. Expression of F-Luc-CG10011 is strongly re-
duced by coexpression of miR-12, while expression of
F-Luc-Nerfin or F-Luc-Vha68-1 is inhibited by coexpres-
sion of miR-9b (Fig. 5E; Rehwinkel et al. 2005, 2006).
Analysis of the steady-state levels of the reporters in-
Figure 5. GW182 triggers decay by promoting dead-
enylation and decapping. (A) RNA samples shown in
Figure 4G (lanes corresponding to time 0 and 15 min)
were treated with RNase H in the absence or presence
of oligo(dT) and analyzed by Northern blot. (B) S2 cells
depleted of GFP, CAF1, NOT1, or DCP1:DCP2 were
transfected with plasmids for the N-tethering assay as
described in Figure 4. F-Luc activities and mRNA levels
were quantitated in three independent experiments,
normalized to that of the Renilla control, and set to 100
in cells expressing the N-peptide alone for each
knockdown (black bars). (C) Northern blot of represen-
tative RNA samples corresponding to B. (D) RNA
samples shown in C and corresponding to the DCP1 + 2
knockdowns were treated with RNase H in the absence
or presence of oligo(dT) and analyzed by Northern blot.
(E) S2 cells were transfected with plasmids expressing
miRNA reporters (Nerfin, Vha68-1, or CG10011), plas-
mids expressing miR-9b or miR-12 (gray bars), or the
corresponding empty vector (black bars), as indicated.
R-Luc served as a transfection control. Firefly luciferase
activity and the corresponding mRNA levels were mea-
sured and normalized to those of the Renilla control.
Normalized firefly luciferase activities and mRNA lev-
els in cells transfected with the empty vector (black
bars) were set to 100%. Error bars represent standard
deviations from at least three independent experi-
ments. (F) Northern blot of representative samples
shown in E.
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dicated that miRNAs trigger reductions in mRNA levels
to different extents (Fig. 5E,F). When we compared the
luciferase activity to the mRNA levels we saw that miR-
9b led mainly to a net decrease in protein expression
from the Nerfin reporter. In contrast, silencing of F-Luc-
CG10011 by miR-12 can be attributed entirely to the
reduction of mRNA levels (Fig. 5E,F). The Vha68-1 re-
porter displayed an intermediate behavior with effects
on both protein expression and mRNA levels (Fig. 5E,F).
Thus, like GW182, miRNAs silence gene expression by
inhibiting protein expression and/or by reducing mRNA
levels.
We next transfected the miRNA reporters together
with the cognate miRNAs into cells depleted of GW182,
CAF1, NOT1, or the DCP1:DCP2 decapping complex.
As a control, cells depleted of AGO1 or GFP were also
transfected. For the three reporters, depletion of AGO1
or GW182 relieved the inhibition of luciferase expres-
sion caused by the miRNAs (Figs. 6A,B, 7A). In agree-
ment with this, reporter mRNA levels (in particular
F-Luc-Vha68-1 and F-Luc-CG10011 mRNAs) were re-
stored, indicating that mRNA decay triggered by miRNAs
requires both AGO1 and GW182 (Figs. 6A–D, 7A). No-
tably, endogenous Vha68-1 and CG10011 mRNAs are
Figure 6. mRNA decay triggered by miRNAs occurs by a deadenylation and decapping mechanism requiring GW182. (A,B) S2 cells
depleted of GFP, AGO1, GW182, CAF1, NOT1, or the DCP1:DCP2 decapping complex were transfected with plasmids expressing the
miRNA reporters described in Figure 5E. Firefly luciferase activity and the corresponding mRNA levels were measured and normalized
to those of the Renilla control. Normalized firefly luciferase activities and mRNA levels in cells transfected with the empty vector
(black bars) were set to 100% for each knockdown. Error bars represent standard deviations from three independent experiments. (C,D)
Northern blot of representative samples shown in A and B. (E,F) RNA samples shown in C and D, lanes corresponding to the DCP1 + 2
knockdown, were treated with RNase H in the absence or presence of oligo(dT) and analyzed by Northern blot. (G,H) S2 cells treated
with dsRNAs targeting GFP or AGO1 were transfected with plasmids for the N-tethering assay. Firefly luciferase activity and the
corresponding mRNA levels were measured and normalized to those of the Renilla control as described in Figure 5. (H) Northern blot
of representative mRNA samples shown in G.
GW182 links the miRNA pathway to mRNA decay
GENES & DEVELOPMENT 1893
 Cold Spring Harbor Laboratory Press on April 2, 2014 - Published by genesdev.cshlp.orgDownloaded from 
also up-regulated in AGO1- or GW182-depleted cells
(Figs. 1E, 7B; Nerfin mRNA is not expressed in S2 cells).
In NOT1-depleted cells we observed a full restoration
of mRNA levels for the reporters for which the cognate
miRNA triggered degradation (i.e., CG10011 and Vha68-
1) (Figs. 6B,D, 7A). For these reporters we also observed a
partial restoration of luciferase expression (Figs. 6B, 7A).
Restoration was also observed, but was less pronounced,
in cells depleted of CAF1 (Figs. 6B,D, 7A). In contrast,
silencing of the Nerfin reporter, which occurs mainly at
the translational level, was not relieved in cells depleted
of CAF1 or NOT1 (Fig. 6A,C).
Depletion of the DCP1:DCP2 decapping complex led
to a complete restoration of mRNA levels for the three
reporters (Figs. 6A–D, 7A). The accumulated transcripts
were deadenylated, as judged by the unchanged mobility
in the presence of oligo(dT) and RNase H (Fig. 6E,F). Re-
markably, although the levels of the Nerfin reporter are
not strongly affected by miR-9b, the mRNA is deadenyl-
ated in cells depleted of DCP1:DCP2 (Fig. 6E). The accu-
mulation of deadenylated transcripts in cells depleted of
the decapping enzymes appears to be specific to mRNAs
undergoing GW182- or miRNA-mediated decay, because
mRNAs that are not regulated by miRNAs are still poly-
adenylated in these cells (e.g., rp49 mRNA, R-Luc
mRNA, and the F-Luc miRNA reporters in the absence
of a cognate miRNA) (Figs. 5D, 6C–F, 7C).
The observation that transcripts accumulating in
DCP1:DCP2-depleted cells are deadenylated provides an
explanation for the lack or partial restoration of lucifer-
ase activity. In contrast, the partial restoration of lucif-
erase activity for the CG10011 and Vha68-1 reporters,
together with the lack of restoration for the Nerfin re-
porter in cells depleted of CAF1 or NOT1, suggests that
translational repression by miRNAs is not relieved in
these cells. We conclude that gene silencing by miRNAs
involves translational repression and/or mRNA dead-
enylation and decapping and both require GW182.
To investigate whether the regulation of the F-Luc re-
porters by coexpressed miRNAs reflects the genuine
miRNA pathway, we performed a similar analysis for
endogenous Vha68-1 and Axs mRNAs, which are pre-
dicted targets of miR-9b and miR-285, respectively.
Vha68-1 and Axs mRNA levels were up-regulated in
cells depleted of AGO1 or GW182, in agreement with
the array data (Figs. 1E,F, 7B). These mRNAs were also
up-regulated in cells depleted of CAF1, NOT1, or of
DCP1:DCP2 (Fig. 7B; data not shown). As observed for
Figure 7. Endogenous miRNA targets are degraded by dead-
enylation and decapping. (A) S2 cells depleted of GFP, AGO1,
GW182, CAF1, NOT1, or the DCP1:DCP2 decapping complex
were transfected with the F-Luc-Vha68-1 reporter. Firefly lucif-
erase activity and the corresponding mRNA levels were mea-
sured and analyzed as described in Figure 6, A and B. (B) Expres-
sion levels of endogenous Vha68-1 mRNA in cells depleted of
AGO1, GW182, CAF1, or DCP1:DCP2. The signals from the
Northern blot were normalized to rp49 mRNA (not shown).
These values are compared with the values measured by micro-
array. Values are given as fold changes relative to the values
obtained cells treated with GFP dsRNA. (n.d.) Not determined.
(C) RNA samples shown in B, lanes corresponding to the control
and the DCP1 + 2 knockdown, were treated with RNase H in
the absence or presence of oligo(dT) and analyzed by Northern
blot. (D,E) The decay of Vha68-1 and Axs mRNAs was moni-
tored in depleted cells following inhibition of transcription by
actinomycin D. The levels of the Vha68-1 and Axs mRNAs
were normalized to rp49 mRNA and plotted against time (not
shown for Vha68-1 mRNA). mRNA half-lives (t1/2) calculated
from the decay curves are indicated.
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the F-Luc reporters, Vha68-1 transcripts accumulating in
DCP1:DCP2-depleted cells were deadenylated (Fig.
7B,C). The increased levels of Vha68-1 and Axs mRNAs
in cells depleted of AGO1, GW182, CAF1, NOT1, or
DCP1:DCP2 were all accompanied by a corresponding
increase in the half-life of the mRNA (Fig. 7D,E).
The results obtained by analyzing endogenous miRNA
targets are qualitatively similar to those obtained with
the F-Luc reporters. However, in contrast to the report-
ers, we observed a stronger stabilization of Vha68-1
mRNA in cells depleted of CAF1, NOT1, or DCP1:DCP2
relative to the stabilization observed in cells depleted of
AGO1 or GW182. The simplest explanation for these
differences is that only a fraction of endogenous Vha68-1
mRNA is degraded by the miRNA pathway. In agree-
ment with this possibility, miR-9b is expressed at very
low levels in S2 cells (Rehwinkel et al. 2006). Thus, for
this and probably other endogenous miRNA targets,
depletion of decapping enzymes and of components of
the CCR4:NOT complex is likely to prevent both nor-
mal decay and decay by miRNAs, giving raise to a stron-
ger stabilization of the mRNA than that observed when
only the miRNA pathway is inhibited.
Tethering of GW182 bypasses the requirement
for AGO1
The results described above, together with previous
studies, show that GW182 is required for silencing of
luciferase expression mediated by miRNAs (Fig. 6; Jaky-
miw et al. 2005; Liu et al. 2005b; Meister et al. 2005;
Rehwinkel et al. 2005). It was therefore of interest to
investigate whether silencing triggered by GW182 re-
quired AGO1. To address this question, we performed
the tethering assays in cells depleted of AGO1. The in-
hibition of luciferase expression and the reduction of
mRNA levels caused by tethering of GW182 were not
relieved in cells depleted of AGO1 (Fig. 6G,H). This lack
of restoration in AGO1-depleted cells cannot be ex-
plained by inefficient depletion, because silencing of the
miRNA reporters was relieved in these cells (Fig. 6A–D).
Thus, depletion of AGO1 prevented miRNA-mediated
silencing but not silencing elicited by tethering of
GW182. We conclude that tethering of GW182 bypasses
the requirement for AGO1. Although the possibility that
AGO2 substitutes for AGO1 when the latter is depleted
cannot be ruled out, we consider it unlikely as AGO2 did
not interact detectably with GW182.
Discussion
The results presented here together with previous stud-
ies (Ding et al. 2005; Jakymiw et al. 2005; Liu et al.
2005b; Meister et al. 2005; Rehwinkel et al. 2005) indi-
cate that GW182 is a genuine component of RNA silenc-
ing pathways, associating with the Argonaute proteins
and with components of the mRNA decay machinery
and, providing a molecular link between RNA silencing
and mRNA degradation.
Drosophila GW182 is a component
of the miRNA pathway
Depletion of GW182 or AGO1 from Drosophila cells
leads to correlated changes in mRNA expression profiles,
indicating that these proteins act in the same pathway.
Transcripts commonly up-regulated by AGO1 and
GW182 are enriched in predicted and validated miRNA
targets. These results, together with the observation that
GW182 associates with AGO1, identify GW182 as a
component of the miRNA pathway.
GW182 belongs to a protein family with GW repeats, a
central UBA domain, and a C-terminal RRM. Multiple
sequence alignment of all proteins possessing these do-
mains revealed that there are three paralogs (TNRC6A/
GW182, TNRC6B, and TNRC6C) in vertebrates, a single
ortholog in insects, and no orthologs in worms or fungi.
At present, it is unclear whether the vertebrate paralogs
have redundant functions, but both GW182 and
TNRC6B have been shown to associate with human
AGO1 and AGO2 (Jakymiw et al. 2005; Liu et al. 2005b;
Meister et al. 2005).
In Drosophila, GW182 interacts with AGO1 in vivo
and in vitro. We could not detect a stable interaction
with AGO2 under the same conditions, suggesting that
AGO2 may act independently of GW182. This is consis-
tent with the observation that depletion of GW182 does
not affect siRNA-guided mRNA cleavage or RNAi,
which is mediated exclusively by AGO2 in Drosophila
(Okamura et al. 2004; Miyoshi et al. 2005; Rehwinkel et
al. 2005). Nevertheless, since AGO2 also regulates the
expression levels of a subset of miRNA targets (Reh-
winkel et al. 2006), the lack of interaction with GW182
raises the question of whether this regulation occurs by
a similar or different mechanism from that mediated by
AGO1. Further studies are needed to elucidate the
mechanism by which Drosophila AGO2 regulates the
expression of a subset of miRNA targets.
GW182 has a conserved modular domain organization
The N-terminal GW repeat region of GW182 encom-
passes two highly conserved motifs (I and II) and is ex-
panded in vertebrates. This region is shorter in insects
and bears similarity to the GW-like regions in the C.
elegans protein AIN-1, involved in the miRNA pathway
(Ding et al. 2005). However, AIN-1 does not contain
UBA, Q-rich, or RRM domains. This lack of common
domain architecture suggests that AIN-1 represents a
functional analog. Nevertheless, the observation that C.
elegans AIN-1 also localizes to P-bodies and interacts
with AGO1 (i.e., worm ALG-1), and the finding that the
N-terminal GW repeats of Drosophila GW182 interact
with the PIWI domain of AGO1, suggest a conserved role
for these repeats in mediating the interaction with Ar-
gonaute proteins. It would be of interest to determine the
molecular basis of the specific interaction between the
N-terminal GW repeats of GW182 and the PIWI domain
of AGOs, and whether this interaction affects the cata-
lytical activity of the domain.
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Apart from the interaction with AGO1, the N-termi-
nal repeats and the UBA and Q-rich domains contribute
to the localization of GW182 in P-bodies, which is in
turn required for P-body integrity (Eystathioy et al. 2002,
2003). This suggests that GW182 may act as a molecular
scaffold bringing together AGO1-containing RISCs and
mRNA decay enzymes, possibly nucleating the assem-
bly of P-bodies. Understanding the precise role of the
various GW182 domains in the interaction with mRNA
decay enzymes and AGO1 as well as in P-body integrity
awaits further biochemical characterization.
GW182 silences the expression of bound transcripts
by inhibiting protein expression and promoting
mRNA decay
Tethering GW182 to a reporter transcript silences its ex-
pression, bypassing the requirement for AGO1. Silencing
by GW182 occurs by two distinct mechanisms: repres-
sion of protein expression, and mRNA degradation. It
remains to be elucidated how GW182 represses transla-
tion. We show that mRNA degradation by GW182 is
inhibited in cells depleted of CAF1, NOT1, or the
DCP1:DCP2 complex, indicating that GW182 promotes
mRNA deadenylation and decapping. Thus, binding of
GW182 appears to be a point of no return, which marks
transcripts as targets for degradation.
More studies are needed to determine whether decap-
ping triggered by GW182 requires prior deadenylation or
whether these two events occur independently. The ob-
servation that mRNA levels are fully restored in cells
depleted of DCP1:DCP2, suggests that deadenylation fol-
lowed by 3-to-5 exonucleolytic degradation is unlikely
to represent a major pathway by which these mRNAs are
degraded. Future studies should also reveal the identity
of the nuclease(s) acting downstream of the decapping
enzymes.
miRNAs silence gene expression
in a GW182-dependent manner
Previous studies indicate that miRNAs can reduce the
levels of the targeted transcripts, and not just the expres-
sion of the translated protein (Bagga et al. 2005; Lim et al.
2005; Giraldez et al. 2006; Rehwinkel et al. 2006; Wu et
al. 2006). Consistently, transcripts up-regulated in cells
depleted of AGO1 or GW182 are enriched in predicted
and validated miRNA targets (Rehwinkel et al. 2006;
this study). In this paper we provide further evidence
indicating that miRNAs silence gene expression by two
mechanisms: one mechanism involving translational si-
lencing, and one involving mRNA degradation. The con-
tribution of these mechanisms to miRNA-mediated gene
silencing appears to differ for each miRNA:target pair.
Indeed, of the three reporters we have analyzed, Nerfin is
silenced mainly at the translational level, silencing of
the CG10011 reporter can be attributed to mRNA deg-
radation, while Vha68-1 is regulated both at the transla-
tional and mRNA levels. Regardless of the extent of the
contribution of these two mechanisms to silencing, both
require AGO1 and GW182, because the levels of the
mRNA reporter and luciferase activity are restored in
cells depleted of any of these two proteins.
In contrast, although the levels of the mRNA reporter
are restored in cells depleted of CAF1 or NOT1, transla-
tional repression is not fully relieved, indicating that
deadenylation is required for mRNA decay, but not for
translational silencing by miRNAs. In agreement with
this, two reports published while this manuscript was in
preparation have shown that miRNAs trigger accelerated
deadenylation of their targets (Giraldez et al. 2006; Wu et
al. 2006). Our study extends these observations further
by demonstrating: First, deadenylation is mediated by
the CCR4:NOT complex; second, decapping is also re-
quired for miRNA target degradation; finally, we show
that both deadenylation and decapping triggered by
miRNAs requires GW182.
Based on the results presented in this study and the
observations that GW182 associates with AGO1 and is
required for miRNA-mediated gene silencing (Ding et al.
2005; Jakymiw et al. 2005; Liu et al. 2005b; Meister et al.
2005; Rehwinkel et al. 2005), we propose the following
model: AGO1-containing RISCs binds to mRNA targets
by means of base-pairing interactions with miRNAs;
AGO1 may then recruit GW182, which marks the tran-
scripts as targets for decay via a deadenylation and de-
capping mechanism.
A question that remains open is whether miRNA-me-
diated translational repression is the cause of mRNA
degradation or whether these represent two independent
mechanism by which miRNAs silence gene expression
as proposed by Wu et al. (2006). Indeed, changes in
mRNA levels are not observed for all miRNA targets
(Rehwinkel et al. 2006), suggesting that inhibition of
translation is not always followed by mRNA decay. Con-
versely, depletion of CAF1 or NOT1 prevents mRNA
decay but does not relieve translational silencing, sug-
gesting that these two processes are independent.
An important finding is that miRNAs elicit degrada-
tion to different extents. One possible explanation is that
the extent of degradation depends on the stability of the
miRNA:mRNA duplexes. Also, the extent of degrada-
tion might depend on the particular set of proteins asso-
ciated with a given target. For instance, some targets
may assemble with a set of proteins that antagonize deg-
radation. Finally, GW182 might interact only with a sub-
set of AGO1-containing RISCs, as suggested for AIN-1
(Ding et al. 2005). A major challenge will be to identify
the specific features of miRNA targets and/or RISC com-
plexes that lead to regulation of gene expression at the
level of translation or at the level of mRNA stability.
Materials and methods
RNAi and genome-wide expression analysis
RNAi was performed essentially as described by Rehwinkel et
al. (2004, 2006). Total RNA was isolated from control and de-
pleted cells using peqGOLD TriFast reagent (peqlab Biotech-
Behm-Ansmant et al.
1896 GENES & DEVELOPMENT
 Cold Spring Harbor Laboratory Press on April 2, 2014 - Published by genesdev.cshlp.orgDownloaded from 
nologie). To reduce potential variations in the preparation of the
RNA, two RNA preparations were isolated from a single knock-
down experiment. Pools of two RNA preparations from a single
knockdown are referred to as RNA samples.
High-density oligonucleotide microarrays (Affymetrix-Dro-
sophila array 2) covering >18,500 transcripts from Drosophila
were used. The microarray results have been submitted to the
ArrayExpress database at EBI under accession number E-MEXP-
487. Standard Affymetrix protocols were used for preparation of
biotinylated targets, hybridization, and data acquisition. Con-
trol parameters were within recommended limits. All experi-
ments were normalized using an intensity-dependent normal-
ization scheme (Lowess). When two independent total RNA
samples were compared, all spots after intensity-dependent nor-
malization had an average ratio of 1.08 ± 0.54. We therefore ap-
ply a twofold cutoff to identify regulated transcripts.
Sequence analysis
Sequence similarity searches were performed using PSI-BLAST
(Altschul et al. 1997), with Drosophila and human GW182 as
input sequences. A group of putatively related sequences was
defined on the basis of the presence of GW repeats and a C-
terminal RRM. The relationship between these proteins was
confirmed by using each of the sequences as an input for PSI-
BLAST and retrieving all the other members of the group.
Transfection of S2 cells, RNA analysis, and luciferase assays
Plasmids allowing the expression of miRNA primary tran-
scripts, miRNA reporters, and the F-Luc-5BoxB plasmid are de-
scribed by Rehwinkel et al. (2005) and Stark et al. (2005). For the
expression of N-HA-peptide fusions, cDNAs encoding full-
length GW182 or protein domains were amplified with primers
containing appropriate restriction sites, using a (dT)15-primed
S2 cDNA library as a template. The amplified cDNAs were
cloned into a vector allowing the expression of N-HA-peptide
fusions (pAc5.1-N-HA).
Transfections were performed in six- or 24-well dishes using
Effectene transfection reagent (Qiagen). For the N-tethering
assay, the following plasmids were cotransfected: 0.15 µg re-
porter plasmid (F-Luc-5BoxB or F-Luc), 0.4 µg pAc5.1-R-Luc as
transfection control, and 5 ng to 1 µg pAc5.1N-HA construct
for the expression of N-HA fusions. To test miRNA function,
the following plasmids were cotransfected: 0.1 µg of firefly lu-
ciferase reporter plasmid, 0.3 µg pAc5.1-R-Luc as transfection
control, and 1 µg of pAc5.1 plasmid without insert (empty vec-
tor) or expressing miRNA primary transcripts.
Three days after transfection, firefly and Renilla luciferase
activities were measured using the Dual-Luciferase reporter as-
say system (Promega), and total RNA was isolated using TriFast
(peqlab biotechnologies). RNA samples were analyzed as de-
scribed by Rehwinkel et al. (2004).
For the measurement of mRNA half-lives, transfected cells
were treated with actinomycin D (5 µg/mL final concentration)
3 d after transfection, and harvested at the time points indi-
cated. RNase H (USB) digestion using a (dT)15 oligonucleotide
was performed according to the manufacturer’s instructions.
Fluorescence microscopy
S2 cells were allowed 15 min to adhere to poly-D-Lysine-coated
coverslips, fixed with 3.7% paraformaldehyde in PBS for 10 min,
and permeabilized for 15 min with PBS containing 0.1% Triton
X-100. HA-tagged proteins were detected with monoclonal anti-
HA antibody (Covance Research Products) diluted 1:1000 in
PBS containing 1% bovine serum albumin (BSA). TRITC-
coupled goat secondary antibody (Molecular Probes) was used in
a dilution of 1:250. For detection of endogenous GW182, S2 cells
were fixed with 90% Methanol and 10% formaldehyde, perme-
abilized with 0.1% Triton X-100 in PBS, and stained with affin-
ity-purified anti-GW182 antibody diluted 1:400 in PBS contain-
ing 1% BSA. DNA was stained with Hoechst 33342 (Molecular
Probes). Cells were mounted using Fluoromount-G (Southern
Biotechnology Associates, Inc.). Images were acquired using a
Zeiss LSM510 META confocal microscope.
Western blots, coimmunoprecipitations, and GST pull-downs
Western blotting was performed with polyclonal anti-HA anti-
bodies (Sigma) or anti-GW182 antibodies, using the CDP-Star
chemiluminescent immunoblot system (PE Biosystems). Dro-
sophila AGO1 was detected using a rabbit polyclonal antibody
(AbCam). The primary antibodies were diluted 1:1000 and de-
tected with alkaline-phosphatase-coupled secondary antibodies
(Western-Star kit from Tropix).
For coimmunoprecipitations, S2 cells were collected 3 d after
transfection, washed with PBS, and lysed for 15 min on ice in
NET buffer (50 mM Tris at pH 7.4, 150 mM NaCl, 1 mM EDTA,
0.1% NP40). Cells were spun at 13,000 rpm for 15 min at 4°C.
Anti-HA antibodies (Covance) were added to the supernatants
(2.5 µL/2 × 106 cells). After 1 h at 4°C, 25 µL of Protein G-
agarose (Roche) were added and the mixtures were rotated for 1
h at 4°C. Beads were washed three times with NET buffer and
once with PBS. Bound proteins were eluted with protein sample
buffer.
For synthesis of [35S]-labeled in vitro translated proteins, the
combined in vitro transcription/translation (TnT) kit from Pro-
mega was used following the manufacturer’s instructions. GST
and GST-GW182 (1–592) were expressed in Escherichia coli
BL21(DE3).
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